Prof Dr Prabir Kumar Das, Secretary General of the Chattogram Heart Foundation and former Head of the Department of ...

CellProthera, a regenerative cell therapy developer specializing in ischemic diseases, announced it will be presenting next week at Terrapinn’s Advanced Therapies Congress 2025, held in London. Ibon ...

New Delhi: Mylan Pharmaceutical has got approval from the Subject Expert Committee (SEC) functional under the Central Drug ...

In patients with acute heart failure, it is unclear how body mass index affects clinical outcomes following acute myocardial infarction.

Research has linked higher levels of air pollution to the risk of acute myocardial infarctions, or heart attacks. How these ...

Cardiovascular disease is a general term that refers to many different types of heart problems. Heart disease is the No. 1 ...

Bengaluru: Amid the sudden loss of a leopard and a sloth bear, Bannerghatta Biological Park (BBP) witnessed the birth of six ...

In recent years, the rate of cardiovascular mortality following high-risk myocardial infarction has significantly declined.

De-escalating dual antiplatelet therapy from from aspirin plus ticagrelor to aspirin plus clopidogrel after primary ...

A new review published in Genes & Diseases highlights macrophage-targeted therapy as a promising frontier in cardiac regeneration and myocardial repair.

A KAIST research team led by Professor Keon Jae Lee has proposed an innovative theoretical framework and research strategies ...